Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
TIE
>>
Phase 1
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
CDP-1
(cetuximab biosimilar) / Guilin SanJin Group
JY028
(bevacizumab biosimilar) / Beijing Eastern Biotech
MEDI-3617
/ AstraZeneca
Alymsys
(bevacizumab-maly) / Amneal, Pharmaceutical Libbs, Grupo Insud, Nichi-Iko, Stada
RPH-001
(bevacizumab biosimilar) / R-Pharm, Alphamab
Retinostat
(OXB-201) / Oxford Biomedica
abequolixron
(RGX-104) / Inspirna
conbercept eye drop
(KH906) / Chengdu Kanghong Pharma
AK-3008
(bevacizumab biosimilar) / Aosaikang Pharma, Anhui Anke Biotech
ALM201
/ Almac Discovery
Anbeisi
(bevacizumab biosimilar) / Sino Biopharm
CVX-241
/ Pfizer
DS-7080a
/ Daiichi Sankyo
EB-203
/ EyebioKorea
HB002.1M
/ Zhejiang Huahai Pharma
JHL1149
(bevacizumab biosimilar) / Eden Biologics
Jotrol
(trans-resveratrol oral) / Jupiter Neurosci
PB101
/ Panolos Biosci
PEG-Endostar
(pegylated recombinant human endostatin) / Simcere
PMC-403
/ PharmAbcine
PPI 2458
/ GSK
Zutrab
(bevacizumab biosimilar) / Laboratorios Richmond
altiratinib
(DCC-2701) / Ono Pharma
foslinanib extended release
(CVM-1118 ER) / TaiRx
roneparstat
(LB401) / Leadiant Biosci
transferrin-tumstatin
(OCU200) / Ocugen
